ロード中...
Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia
BACKGROUND: We evaluated if the survival benefit of adding rituximab to standard chemotherapy for non-Hodgkin lymphoma (NHL) observed in clinical trials has been experienced by an Australian NHL patient population. METHODS: NHL cases diagnosed in 1985-2004 in New South Wales (NSW) were followed-up t...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2886045/ https://ncbi.nlm.nih.gov/pubmed/20497580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-231 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|